Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly

被引:230
作者
Beauregard, C
Truong, U
Hardy, J
Serri, O
机构
[1] Univ Montreal, Hop Notre Dame, CHUM, Serv Endocrinol, Montreal, PQ H2L 4M1, Canada
[2] Univ Montreal, Hop Notre Dame, CHUM, Neurosurg Serv, Montreal, PQ H2L 4M1, Canada
关键词
D O I
10.1046/j.1365-2265.2003.01679.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Acromegaly has long been associated with increased mortality but few long-term follow-up data are available in patients treated for this disease. We therefore studied a group of 103 patients who underwent transsphenoidal adenomectomy for acromegaly between 1970 and 1999 and were followed for one to 30 years. DESIGN AND PATIENTS A retrospective chart review was performed on 103 patients living in the province of Quebec, Canada. Mortality data were obtained by hospital charts, contact with the patient's family or death certificates. Stringent biochemical criteria were used to define remission (random GH < 2.5 μg/l, or GH nadir after an oral glucose load is < 1 mug/l and IGF-I within the normal range) and patient survival in the group in remission and the group with persistent disease were compared to survival of the population of Quebec, Canada, using the probabilities of the Poisson distribution. RESULTS There were four deaths in the perioperative period, one of which was directly related to surgery. Initial remission was obtained in 82% of microadenomas, 60% of macroadenomas and 24% of invasive adenomas. The long-term (greater than or equal to 10 years) remission rate for surgery alone was 52%. A second transsphenoidal surgery, radiation therapy and/or octreotide were used in a subset of patients with persistent disease. Long-term remission was obtained in 63% of patients. Five (mean age, 64 years) of the 57 patients in remission died; this rate did not differ significantly from the mortality rate expected in the general population (P = 0.18). Thirteen (mean age, 59.8 years) of the 34 patients with persistent disease died; this rate was significantly higher than that expected in the general population (P = 0.008). CONCLUSIONS Our observations confirm that uncontrolled acromegaly increases mortality compared to the general population and that mortality rates similar to the general population are restored once remission is induced.
引用
收藏
页码:86 / 91
页数:6
相关论文
共 22 条
[1]   Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results [J].
Abosch, A ;
Tyrrell, JB ;
Lamborn, KR ;
Hannegan, LT ;
Applebury, CB ;
Wilson, CB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10) :3411-3418
[2]  
Ahmed S, 1999, CLIN ENDOCRINOL, V50, P561
[3]   EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION [J].
ALEXANDER, L ;
APPLETON, D ;
HALL, R ;
ROSS, WM ;
WILKINSON, R .
CLINICAL ENDOCRINOLOGY, 1980, 12 (01) :71-79
[4]   The effect of hypopituitarism on life expectancy [J].
Bates, AS ;
VantHoff, W ;
Jones, PJ ;
Clayton, RN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :1169-1172
[5]   DOES TREATMENT OF ACROMEGALY AFFECT LIFE EXPECTANCY [J].
BATES, AS ;
VANTHOFF, W ;
JONES, JM ;
CLAYTON, RN .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (01) :1-5
[6]  
BENGTSSON BA, 1988, ACTA MED SCAND, V223, P327
[7]   Ten-year follow-up results of transsphenoidal microsurgery in acromegaly [J].
Biermasz, NR ;
Van Dulken, H ;
Roelfsema, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4596-4602
[8]  
BRESLOW NE, 1987, IARC SCI PUBL, V32, P131
[9]   Increased cerebrovascular mortality in patients with hypopituitarism [J].
Bulow, B ;
Hagmar, L ;
Mikoczy, Z ;
Nordstrom, CH ;
Erfurth, EM .
CLINICAL ENDOCRINOLOGY, 1997, 46 (01) :75-81
[10]  
Collins WF., 1979, CLIN MANAGEMENT PITU, P335